IP Library Granted Patent US 8,304,595
Granted Patent B2
US 8,304,595 · App. 12/329,431 · Granted Nov 6, 2012

Resorbable nanoenhanced hemostatic structures and bandage materials

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,304,595
App. No.
12/329,431
Granted
Nov 6, 2012
Kind
B2
Abstract

Methods, systems, and apparatuses for nanomaterial-enhanced hemostatic medical devices are provided. Hemostatic materials and structures are provided that induce coagulation of blood at a wound/opening caused by trauma, a surgical procedure, ulceration, or other cause. The hemostatic materials and structures may incorporate nanostructures and/or further hemostatic elements such as polymers and/or glass beads. The hemostatic materials and structures may be resorbable. Example embodiments include hemostatic bandages, hemostatic plugs, and hemostatic formulations.

Claims (40)

1. A hemostatic structure, comprising:

a base structure that includes a first material; and

a plurality of nanostructures incorporated with the base structure, wherein the nanostructures include at least one of nanofibers or nanorods;

wherein the nanostructures comprise at least one semiconductor material and are configured to induce hemostasis when the hemostatic structure is contacted with blood.

2. The hemostatic structure of claim 1 , wherein the base structure includes a woven or nonwoven fiber of the first material.

3. The hemostatic structure of claim 2 , wherein the first material is a natural fiber.

4. The hemostatic structure of claim 2 , wherein the first material is a synthetic fiber.

5. The hemostatic structure of claim 2 , wherein the fiber is a glass microfiber.

6. The hemostatic structure of claim 1 , wherein the nanostructures include silicon nanowires.

7. The hemostatic structure of claim 6 , wherein the silicon nanowires have a thin naturally occurring oxide shell layer.

8. The hemostatic structure of claim 1 , wherein the nanostructures coat the base structure.

9. The hemostatic structure of claim 1 , wherein the first material is resorbable.

10. The hemostatic structure of claim 1 , wherein the first material includes cotton.

11. The hemostatic structure of claim 1 , wherein the first material includes oxidized cellulose.

12. The hemostatic structure of claim 1 , wherein the first material includes collagen.

13. The hemostatic structure of claim 1 , wherein the first material includes a biologically-derived material.

14. The hemostatic structure of claim 1 , wherein the first material is an organic or inorganic polymer.

15. The hemostatic structure of claim 1 , wherein the hemostatic structure is a bandage.

16. The hemostatic structure of claim 1 , wherein the base structure is a bandage.

17. A hemostat, comprising:

a material; and

a plurality of nanostructures comprising at least one semiconductor material, wherein the nanostructures include at least one of nanofibers, nanorods, or nanotubes;

wherein the material and the nanostructures form a mixture.

18. The hemostat of claim 17 , wherein the nanostructures include nanofibers.

19. The hemostat of claim 18 , wherein the nanofibers are coated with silicon dioxide.

20. The hemostat of claim 18 , wherein the nanofibers are potassium nanofibers.

21. The hemostat of claim 18 , wherein the nanofibers are silicon nanofibers functionalized with potassium.

22. The hemostat of claim 17 , wherein the material comprises chitosan.

23. The hemostat of claim 22 , wherein the material comprises chitosan microparticles.

24. The hemostat of claim 17 , wherein the material comprises biocompatible polymers.

25. A method for forming a hemostatic structure, comprising:

incorporating nanostructures with a first material to form the hemostatic structure.

26. The method of claim 25 , wherein said incorporating comprises:

incorporating the nanostructures with a weave of fibers of the first material to form the hemostatic structure; and

coating the weave of fibers with the nanostructures to form the hemostatic structure; and wherein said coating comprises:

sonicating a wafer coated with nanostructures in a liquid;

filtering the sonicated nanostructures;

suspending the filtered nanostructures in a liquid to form a nanostructure suspension;

soaking the weave of fibers in the nanostructure suspension; and

drying the soaked weave of fibers.

Assignments (4)
RELEASE OF SECURITY INTEREST IN INTELLECTUAL PROPERTY COLLATERAL AT REEL/FRAME NO. 49170/0482 Recorded Jul 1, 2021
From: OCEAN II PLO, LLC, AS AGENT
To: NANOSYS, INC.
Reel/Frame 056752/0073 →
SECURITY INTEREST Recorded Jan 17, 2019
From: NANOSYS, INC.
To: OCEAN II PLO, LLC
Reel/Frame 049170/0482 →
CONFIRMATORY LICENSE Recorded Dec 6, 2013
From: NANOSYS INCORPORATED
To: NAVY, SECRETARY OF THE UNITED STATES OF AMERICA
Reel/Frame 031957/0312 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 9, 2009
From: DANIELS, R. HUGH; DUBROW, ROBERT S.; ENZERINK, ROBERT; LI, ESTHER; SAHI, VIJENDRA; GOLDMAN, JAY L.; PARCE, J. WALLACE
To: NANOSYS, INC.
Reel/Frame 022225/0065 →